跳至主要内容
临床试验/NCT01753427
NCT01753427已完成不适用

Perception of Symptom Variability in Chinese COPD Patients

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,058 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,058
试验地点
1
主要终点
The variability of symptoms due to COPD throughout the day

研究概览

简要总结

The objective of the study is to assess patient's perception with stable state COPD on symptom variability and to describe how symptom variability impacts daily quality of life in Chinese COPD patient with moderate, severe or very severe airflow limitation from tier 3 hospitals in China where most of COPD patients are diagnosed and treated.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of subject informed consent
  • Out-patient
  • Clinical diagnosis of COPD at least 6 months
  • Lung function based on data available within 3 months in medical records confirming FEV1<80% normal predicted (post-bronchodilator) and FEV1/FVC<0.7 (post-bronchodilator)

排除标准

  • Participation in any interventional study involving investigational drugs; Patient inability to understand the study procedures or inability/reluctance to answer questionnaire
  • Ongoing exacerbation of COPD or exacerbation within the previous 3 months. An exacerbation is defined as a worsening of COPD symptoms leading to a treatment with antibiotics and/or a short course of system steroids and/or hospitalisation or emergency
  • History of asthma and/or allergic rhinitis, Lung cancer or any other significant respiratory disease such as bronchiectasis, lung fibrosis, interstitial lung disease, tuberculosis, sarcoidosis

结局指标

主要结局

The variability of symptoms due to COPD throughout the day

时间窗: Day 1

* To ask subject, which symptoms(breathlessness, chest tightness, coughing, wheezing, phlegm)is COPD symptoms and exist throughout the day * To ask subject , whether COPD symptoms variability throughout the day exists or not ; * To ask subject , which (on waking, later in the morning, in the afternoon, in the evening, at night) is the most likely occurring time of these symptoms; * To ask subject , Which (on waking, later in the morning, in the afternoon, in the evening, at night) is the most troublesome time of these symptoms.

次要结局

  • The impact of COPD symptoms on patient's daily living activities and sleep quality(Day 1)
  • Total CAT score(Day 1)
  • Total MMRC score(Day 1)
  • The impact of COPD symptoms on morning activities(Day 1)
  • Patient's perception on COPD and COPD treatments(Day 1)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Perception of Symptom Variability in COPD | 临床试验